TrialPain medicine (Malden, Mass.)2017

Human Abuse Potential of an Abuse-Deterrent (AD), Extended-Release (ER) Morphine Product Candidate (Morphine-ADER Injection-Molded Tablets) versus Extended-Release Morphine Administered Orally in Nondependent Recreational Opioid Users.

Michael D Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.